![Cancers | Free Full-Text | Treatment of Patients with Monoclonal Gammopathy of Clinical Significance Cancers | Free Full-Text | Treatment of Patients with Monoclonal Gammopathy of Clinical Significance](https://www.mdpi.com/cancers/cancers-13-05131/article_deploy/html/images/cancers-13-05131-g004.png)
Cancers | Free Full-Text | Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
![Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies - eBioMedicine Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies - eBioMedicine](https://www.thelancet.com/cms/attachment/f0deb252-d30c-44fd-a4b2-d96274e800e2/gr1_lrg.jpg)
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies - eBioMedicine
![Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests - ScienceDirect Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379121001543-fx1.jpg)
Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests - ScienceDirect
![Antibodies | Free Full-Text | Monoclonal Antibodies Generated against Glycoconjugates Recognize Chemical Linkers Antibodies | Free Full-Text | Monoclonal Antibodies Generated against Glycoconjugates Recognize Chemical Linkers](https://www.mdpi.com/antibodies/antibodies-09-00048/article_deploy/html/images/antibodies-09-00048-ag.png)
Antibodies | Free Full-Text | Monoclonal Antibodies Generated against Glycoconjugates Recognize Chemical Linkers
![Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine](https://www.thelancet.com/cms/attachment/c798169c-fd55-43b9-94a2-092367281558/gr1_lrg.jpg)
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
![Generation and functional characterization of a single-chain variable fragment (scFv) of the anti-FGF2 3F12E7 monoclonal antibody | Scientific Reports Generation and functional characterization of a single-chain variable fragment (scFv) of the anti-FGF2 3F12E7 monoclonal antibody | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-80746-8/MediaObjects/41598_2020_80746_Fig1_HTML.png)
Generation and functional characterization of a single-chain variable fragment (scFv) of the anti-FGF2 3F12E7 monoclonal antibody | Scientific Reports
![Mouse Monoclonal Antibody against Human IFN-Alpha/Beta Receptor 1, Clone MMHAR-3 | PBL Assay Science Mouse Monoclonal Antibody against Human IFN-Alpha/Beta Receptor 1, Clone MMHAR-3 | PBL Assay Science](https://www.pblassaysci.com/sites/default/files/styles/image_gallery_enlarge/public/2022-07/21370-1_Log%20Flourescence%20Fig%204_.jpg?itok=okPIjAW7)
Mouse Monoclonal Antibody against Human IFN-Alpha/Beta Receptor 1, Clone MMHAR-3 | PBL Assay Science
![Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All](https://www.mdpi.com/cancers/cancers-12-01554/article_deploy/html/images/cancers-12-01554-g001.png)
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
![Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Cell Discovery Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Cell Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41421-021-00347-1/MediaObjects/41421_2021_347_Fig1_HTML.png)
Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Cell Discovery
![Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy](https://www.frontiersin.org/files/Articles/697876/fcimb-11-697876-HTML/image_m/fcimb-11-697876-g001.jpg)
Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
![Cancers | Free Full-Text | Treatment of Patients with Monoclonal Gammopathy of Clinical Significance Cancers | Free Full-Text | Treatment of Patients with Monoclonal Gammopathy of Clinical Significance](https://www.mdpi.com/cancers/cancers-13-05131/article_deploy/html/images/cancers-13-05131-g002.png)